These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 11719439)
1. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439 [TBL] [Abstract][Full Text] [Related]
2. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course. Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327 [TBL] [Abstract][Full Text] [Related]
5. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
7. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344 [TBL] [Abstract][Full Text] [Related]
8. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475 [TBL] [Abstract][Full Text] [Related]
9. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Lasota J; Jasinski M; Sarlomo-Rikala M; Miettinen M Am J Pathol; 1999 Jan; 154(1):53-60. PubMed ID: 9916918 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Miettinen M; Lasota J Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876 [TBL] [Abstract][Full Text] [Related]
11. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. Heinrich MC; Corless CL; Demetri GD; Blanke CD; von Mehren M; Joensuu H; McGreevey LS; Chen CJ; Van den Abbeele AD; Druker BJ; Kiese B; Eisenberg B; Roberts PJ; Singer S; Fletcher CD; Silberman S; Dimitrijevic S; Fletcher JA J Clin Oncol; 2003 Dec; 21(23):4342-9. PubMed ID: 14645423 [TBL] [Abstract][Full Text] [Related]
12. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of gastric stromal tumors. Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317 [TBL] [Abstract][Full Text] [Related]